American College Of Neuropsychopharmacology Inc
Stable Revenue, Strong Asset Growth, and Low Liabilities for Neuropsychopharmacology Group
EIN: 221736045 · Brentwood, TN · NTEE: G96C · Updated: 2026-04-04
Is American College Of Neuropsychopharmacology Inc Legit?
Appears Legitimate
Assessment based on IRS 990 filings, spending patterns, and AI analysis. Not a guarantee of legitimacy. Full charity check →
American College Of Neuropsychopharmacology Inc directs 75% of its spending to programs. This exceeds the industry benchmark of 65%, indicating strong mission focus.
About American College Of Neuropsychopharmacology Inc
American College Of Neuropsychopharmacology Inc (EIN: 221736045) is a nonprofit organization based in Brentwood, TN, classified under NTEE code G96C. The organization reported total revenue of $8.3M and total assets of $25.9M according to its most recent IRS 990 filing. This transparency report provides an AI-powered analysis of American College Of Neuropsychopharmacology Inc's financial health, spending patterns, executive compensation, and overall mission effectiveness based on publicly available IRS data.
AI Transparency Report
Mission Effectiveness Score
NonprofitSpending's AI analysis rates American College Of Neuropsychopharmacology Inc with a Mission Score of 85 out of 100 (Excellent). This score reflects the organization's overall financial transparency, program spending efficiency, and governance indicators derived from IRS 990 public filings.
Spending Breakdown
- admin: 15%
- programs: 75%
- fundraising: 10%
According to IRS 990 filings, American College Of Neuropsychopharmacology Inc allocates its expenses as follows: admin: 15%, programs: 75%, fundraising: 10%. With 75% directed toward programs, this reflects a strong commitment to its charitable mission.
Executive Compensation Analysis
Executive compensation appears reasonable given the organization's size and mission, with no red flags identified in the available filings.
Executive compensation data is sourced from IRS 990 filings, which require nonprofits to disclose the compensation of officers, directors, trustees, and key employees. NonprofitSpending analyzes this data relative to the organization's total revenue and sector benchmarks to assess whether executive pay is reasonable.
Strengths
The following positive indicators were identified for American College Of Neuropsychopharmacology Inc:
- Consistent revenue generation over multiple years, demonstrating financial stability.
- Significant growth in assets from $11.6M in 2016 to $20.7M in 2023, indicating effective financial management.
- Very low liabilities relative to assets, suggesting strong fiscal responsibility and minimal debt.
- Program expenses consistently represent a substantial portion of total expenses, aligning with mission focus.
Frequently Asked Questions about American College Of Neuropsychopharmacology Inc
Is American College Of Neuropsychopharmacology Inc a legitimate charity?
Based on AI analysis of IRS 990 filings, American College Of Neuropsychopharmacology Inc (EIN: 221736045) appears legitimate. Mission Score: 85/100. 0 red flags identified, 4 strengths noted.
How does American College Of Neuropsychopharmacology Inc spend its money?
American College Of Neuropsychopharmacology Inc directs 75% of its spending to programs and services. The remaining budget covers administration and fundraising costs.
Are donations to American College Of Neuropsychopharmacology Inc tax-deductible?
American College Of Neuropsychopharmacology Inc is registered as a tax-exempt nonprofit (EIN: 221736045). Donations to most 501(c)(3) organizations are tax-deductible. Consult a tax professional for your specific situation.
What does American College Of Neuropsychopharmacology Inc do?
American College Of Neuropsychopharmacology Inc is a nonprofit organization in the Diseases, Disorders & Medical Disciplines sector, located in Brentwood, Tennessee. It is classified under NTEE code G96C.
How much revenue does American College Of Neuropsychopharmacology Inc have?
American College Of Neuropsychopharmacology Inc reported total revenue of $8,279,084. Based on 12 IRS 990 filings on record.
What are American College Of Neuropsychopharmacology Inc's total assets?
American College Of Neuropsychopharmacology Inc holds total assets of $25,932,156 as reported in IRS 990 filings.
Where is American College Of Neuropsychopharmacology Inc located?
American College Of Neuropsychopharmacology Inc is based in Brentwood, Tennessee.
What is American College Of Neuropsychopharmacology Inc's EIN?
American College Of Neuropsychopharmacology Inc's Employer Identification Number (EIN) is 221736045. This is the unique tax ID assigned by the IRS for tax-exempt organizations.
What type of nonprofit is American College Of Neuropsychopharmacology Inc?
American College Of Neuropsychopharmacology Inc is classified under NTEE code G96C (Diseases, Disorders & Medical Disciplines).
Is American College Of Neuropsychopharmacology Inc a registered 501(c)(3)?
Yes, American College Of Neuropsychopharmacology Inc is recognized as a tax-exempt organization by the IRS. EIN: 221736045.
Does American College Of Neuropsychopharmacology Inc file IRS Form 990?
Yes, American College Of Neuropsychopharmacology Inc has 12 IRS Form 990 filings on record. The most recent covers tax period 202303.
What was American College Of Neuropsychopharmacology Inc's revenue in 2023?
In the 202303 filing period, American College Of Neuropsychopharmacology Inc reported total revenue of $3,782,275, total expenses of $3,180,068, and net assets of $20,761,567.
Is American College Of Neuropsychopharmacology Inc's revenue growing or declining?
American College Of Neuropsychopharmacology Inc's revenue is relatively stable. Revenue went from $3,872,941 (202203) to $3,782,275 (202303), a -2.3% change. Based on 12 filings on record.
What is American College Of Neuropsychopharmacology Inc's most recent 990 filing?
The most recent IRS Form 990 filing for American College Of Neuropsychopharmacology Inc covers tax period 202303. It shows revenue of $3,782,275, expenses of $3,180,068, total assets of $20,761,567, and liabilities of $504,719.
How much does American College Of Neuropsychopharmacology Inc spend on programs vs administration?
Based on IRS 990 analysis, American College Of Neuropsychopharmacology Inc allocates approximately 75% of expenses to program services, 15% to administrative costs, and 10% to fundraising. This indicates strong program focus.
Is American College Of Neuropsychopharmacology Inc a trustworthy charity?
Based on AI analysis of IRS 990 data, American College Of Neuropsychopharmacology Inc appears trustworthy. Mission Score: 85/100 (Excellent). No red flags identified. 4 strengths noted.
What are American College Of Neuropsychopharmacology Inc's strengths?
Positive indicators for American College Of Neuropsychopharmacology Inc include: Consistent revenue generation over multiple years, demonstrating financial stability.. Significant growth in assets from $11.6M in 2016 to $20.7M in 2023, indicating effective financial management.. Very low liabilities relative to assets, suggesting strong fiscal responsibility and minimal debt.. Program expenses consistently represent a substantial portion of total expenses, aligning with mission focus.. These findings are derived from AI analysis of the organization's financial filings.
How does American College Of Neuropsychopharmacology Inc compensate executives?
Executive compensation appears reasonable given the organization's size and mission, with no red flags identified in the available filings. Executive compensation data is sourced from IRS 990 filings, which require disclosure of officer, director, and key employee pay.
How has the organization managed to achieve such substantial asset growth while maintaining relatively stable revenue?
The organization has consistently generated more revenue than expenses, allowing for the accumulation of assets. For example, in 2023, revenue was $3,782,275 while expenses were $3,180,068, contributing to asset growth.
What specific strategies are in place to ensure that the low liability levels are maintained in future years?
The consistent surplus of revenue over expenses, as seen in the 2023 filing with a surplus of over $600,000, suggests a prudent financial management approach that prioritizes avoiding debt and building reserves.
Filing History
IRS 990 filing history for American College Of Neuropsychopharmacology Inc showing financial trends over 12 years of public records:
Over 12 years of IRS 990 filings (2012–2023), American College Of Neuropsychopharmacology Inc's revenue has grown by 15.5%, moving from $3.3M to $3.8M. Total assets increased by 148.2% over the same period, from $8.4M to $20.8M. Total functional expenses fell by 2.9%, from $3.3M to $3.2M. In its most recent filing year (2023), American College Of Neuropsychopharmacology Inc reported a surplus of $602K, with revenue exceeding expenses. The organization holds $505K in liabilities against $20.8M in assets (debt-to-asset ratio: 2.4%), resulting in net assets of $20.3M.
| Year | Revenue | Expenses | Assets | Liabilities | Officer Comp. | |
|---|---|---|---|---|---|---|
| 2023 | $3.8M | $3.2M | $20.8M | $505K | — | View 990 |
| 2022 | $3.9M | $2.8M | $21.2M | $365K | — | View 990 |
| 2021 | $3.0M | $1.4M | $19.6M | $331K | — | View 990 |
| 2020 | $3.8M | $3.0M | $13.7M | $230K | — | View 990 |
| 2019 | $3.4M | $2.9M | $14.2M | $240K | — | View 990 |
| 2018 | $3.3M | $2.8M | $13.5M | $263K | — | View 990 |
| 2017 | $2.9M | $2.8M | $12.6M | $376K | — | View 990 |
| 2016 | $2.9M | $2.5M | $11.7M | $488K | — | View 990 |
| 2015 | $2.9M | $2.3M | $11.4M | $374K | — | View 990 |
| 2014 | $3.1M | $2.5M | $10.4M | $211K | — | View 990 |
| 2013 | $3.8M | $3.0M | $9.7M | $504K | — | View 990 |
| 2012 | $3.3M | $3.3M | $8.4M | $420K | — | View 990 |
Year-by-Year Financial Summary
- 2023: Revenue of $3.8M, expenses of $3.2M, and assets of $20.8M (revenue -2.3% year-over-year).
- 2022: Revenue of $3.9M, expenses of $2.8M, and assets of $21.2M (revenue +27.2% year-over-year).
- 2021: Revenue of $3.0M, expenses of $1.4M, and assets of $19.6M (revenue -20.1% year-over-year).
- 2020: Revenue of $3.8M, expenses of $3.0M, and assets of $13.7M (revenue +11.6% year-over-year).
- 2019: Revenue of $3.4M, expenses of $2.9M, and assets of $14.2M (revenue +3.2% year-over-year).
- 2018: Revenue of $3.3M, expenses of $2.8M, and assets of $13.5M (revenue +14.9% year-over-year).
- 2017: Revenue of $2.9M, expenses of $2.8M, and assets of $12.6M (revenue -0.6% year-over-year).
- 2016: Revenue of $2.9M, expenses of $2.5M, and assets of $11.7M (revenue -0.6% year-over-year).
- 2015: Revenue of $2.9M, expenses of $2.3M, and assets of $11.4M (revenue -7.4% year-over-year).
- 2014: Revenue of $3.1M, expenses of $2.5M, and assets of $10.4M (revenue -18.1% year-over-year).
- 2013: Revenue of $3.8M, expenses of $3.0M, and assets of $9.7M (revenue +17.2% year-over-year).
- 2012: Revenue of $3.3M, expenses of $3.3M, and assets of $8.4M.
Data Sources and Methodology
This transparency report for American College Of Neuropsychopharmacology Inc is generated by NonprofitSpending's AI analysis engine. The data is sourced from publicly available IRS 990 filings accessed through the ProPublica Nonprofit Explorer API and IRS electronic filing records. The Mission Score, spending breakdown, and other analytical insights are produced by artificial intelligence and should be used as one of multiple factors when evaluating a nonprofit organization.
IRS 990 forms are annual information returns that most tax-exempt organizations must file with the IRS. These forms provide detailed financial information including revenue, expenses, assets, liabilities, and compensation of officers. NonprofitSpending processes this data to provide accessible transparency reports for donors, researchers, and the general public.
Disclaimer
AI-generated analysis based on IRS public records. Not financial or legal advice. Verify information directly with the organization.